Latest Bacteria Stories
MONTREAL, April 26, 2013 /PRNewswire-iReach/ -- Micropharma Limited, a pioneer in the development of innovative and effective products based on the human microbiome, today announced that after three years of development it has a timeline for launch of its ingestible gastrointestinal sampling technology. The company released its plans to launch the device in late 2014 commercially for research and development use and later for specific clinical applications. Micropharma has been...
Specialised Therapeutics Australia to Launch DIFICID May 14, 2013 JERSEY CITY, N.J., April 26, 2013 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced that the Therapeutic Goods Administration, the Australian regulatory body for therapeutic goods such as medicines, has approved DIFICID® (fidaxomicin) tablets for the treatment of confirmed Clostridium difficile infection (CDI) in adults. DIFICID will be available to patients in Australia starting May 14,...
Lawrence LeBlond for redOrbit.com - Your Universe Online Salmonella outbreaks seem commonplace as of late, with one of the most recent being an outbreak linked to minced meat. Lee Rannals of redOrbit reported in January that 16 people were sickened in five states due to contaminated ground beef. While nobody died from the outbreak, more than half were hospitalized. One of the worst outbreaks in recent memory was the deadly 2009 salmonella outbreak tied to peanut butter, which sickened...
Researchers are 1 step closer to understanding why antibiotics are ineffective against certain types of bacteria Antibiotic resistance is a global problem. The World Health Organisation (WHO) estimates that for tuberculosis alone multi-drug resistance accounts for more than 150,000 deaths each year. WHO warns of "a doomsday scenario of a world without antibiotics," in which antibiotic resistance will turn common infections into incurable killers and make routine surgeries a high-risk...
Bacteria evolve resistance more quickly when stronger antibiotics are used New scientific research published today in the journal PLoS Biology shows that bacteria can evolve resistance more quickly when stronger antibiotics are used. Researchers from the University of Exeter and Kiel University in Germany treated E. coli with different combinations of antibiotics in laboratory experiments. Unexpectedly they found that the rate of evolution of antibiotic resistance speeds up when...
In a study that included nearly 3,000 adults from Denmark, a diagnosis of meningococcal, pneumococcal, or Haemophilus influenzae meningitis in childhood was associated with lower educational achievement and economic self-sufficiency in adult life, according to a study in the April 24 issue of JAMA. Bacterial meningitis may lead to brain damage due to several factors, and survivors of childhood bacterial meningitis are at particular risk of hearing loss, seizure disorders, motor deficits,...
Eravacycline's Competitive Advantages Include Activity Against Multidrug-Resistant Pathogens and Availability in Interchangeable IV and Oral Formulations, According to a New Report from Decision Resources BURLINGTON, Mass., April 24, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, based on clinical data and the opinions of interviewed thought leaders, Tetraphase Pharmaceuticals'...
Our gut is home to trillions of bacteria, numbering more than the cells in the rest of our body, and these bacteria help us to digest our food, absorb nutrients and strengthen our immune system. This complex bacterial ecosystem, called the gut microbiota, also helps to prevent bad bacteria from colonizing our bodies and making us ill. As part of the symbiotic relationship between the gut microbiota and our bodies, the bacteria derive nutrition from our food and convert it into compounds...
EXTON, Pa., April 22, 2013 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM), an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs and rare diseases, today announced the results of a Phase 2 study of VP20621 (non-toxigenic Clostridium difficile; NTCD) a novel treatment approach for preventing recurrent C. difficile infections (CDI). CDI is a common and dangerous gastrointestinal...
University of Cincinnati New research, just published, details how University of Cincinnati researchers have developed and tested a solar-powered nano filter that is able to remove harmful carcinogens and antibiotics from water sources – lakes and rivers – at a significantly higher rate than the currently used filtering technology made of activated carbon. In the journal “Nano Letters,” Vikram Kapoor, environmental engineering doctoral student, and David Wendell, assistant...
Latest Bacteria Reference Libraries
Yersinia enterocolitica is a species of gram-negative coccobacillus-shaped bacterium, belonging to the family Enterobacteriaceae. Infection from Yersinia enterocolitica causes the zoonotic disease yersiniosis. Most infected animals recover from the disease and become asymptomatic carriers. Acute infections lead to mild self-limiting entero-colitis or terminal ileitis in humans. Symptoms include watery or bloody diarrhea and fever. After oral uptake it replicates in the terminal ileum and...
Vibrio vulnificus is a species of Gram-negative, motile, curved, rod-shaped bacteria of the Vibrio Genus. Hollis et al. first reported it in 1976. It was given the name Beneckea vulnifica by Reichelt et al. in 1976 and in 1979 Vibrio vulnificus by Farmer. V. vulnificus is related to V. cholerae and is present in marine environments such as estuaries, brackish ponds, or coastal areas. It causes an infection often incurred after eating seafood, especially raw or undercooked oysters. It can...
Streptococcus mutans is a Gram-positive cocci, Facultative anaerobic bacterium commonly found in the human oral cavity and is a significant contributor to tooth decay. J Kilian Clarke first described the microbe in 1924. The first colonizers of the tooth surface are mainly Neisseria spp. and streptococci, including S. mutans. The pioneer species changes the local environmental conditions through growth and metabolism thus allowing more fastidious organisms to further colonize after them,...
Staphylococcus epidermidis is one of thirty-three known species belonging to the genus Staphylococcus. It is part of our skin flora and can also be found in the mucous membranes and in animals. It is the most common species found in laboratory test due to contamination. It is not usually pathogenic; however, patients with a compromised immune system often risk infection. Infections can be both nosocomial and community acquired and are more of a threat to hospital patients. Hospitals carry...
Staphylococcus aureus is a facultative anaerobic gram-positive coccus, and is the most common cause of staph infections. It is commonly part of the skin flora found in the nose and on skin. Around 20% of the human population is long-term carriers. It gets its golden color due to its carotenoid pigment staphyloxanthin. The pigment acts as a virulence factor with an antioxidant action that allows the microbe to evade death by reactive oxygen species used by the host immune system. Staphylococci...
